Car T Cell Therapy in Large B-Cell Lymphoma

The biggest issue in the benefits of cellular therapy is the brain to vein time. A patient that has a third party payer or has medicare with a managed plan waits weeks to get a for east and we haven't been able to dive into the outcomes of those different patient populations because it's very hard, says dr lonning.